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Background: HIV and malaria are among the leading causes of morbidity and mortality during pregnancy in
Africa. However, data from Congolese pregnant women are lacking. The aim of the study was to determine the
magnitude, predictive factors, clinical, biologic and anthropometric consequences of malaria infection, HIV infection,
and interactions between malaria and HIV infections in pregnant women.
Methods: A cross-sectional study was conducted among pregnant women admitted and followed up at Camp
Kokolo Military Hospital from 2009 to 2012 in Kinshasa, the Democratic Republic of Congo. Differences in means
between malaria-positive and malaria-negative cases or between HIV-positive and HIV-negative cases were
compared using the Student’s t-test or a non-parametric test, if appropriate. Categorical variables were compared
using the Chi-square or Fisher’s exact test, if appropriate. Backward multivariable analysis was used to evaluate
the potential risk factors of malaria and HIV infections. The odds ratios with their 95% confidence interval (95% CI)
were estimated to measure the strengths of the associations. Analyses resulting in values of P < 0.05 were
considered significant.
Results: A malaria infection was detected in 246/332 (74.1%) pregnant women, and 31.9% were anaemic.
Overall, 7.5% (25/332) of mothers were infected by HIV, with a median CD4 count of 375 (191; 669) cells/μL.
The mean (±SD) birth weight was 2,613 ± 227 g, with 35.7% of newborns weighing less than 2,500 g (low birth
weight). Low birth weight, parity and occupation were significantly different between malaria-infected and
uninfected women in adjusted models. However, fever, anemia, placenta previa, marital status and district of
residence were significantly associated to HIV infection.
Conclusion: The prevalence of malaria infection was high in pregnant women attending the antenatal facilities
or hospitalized and increased when associated with HIV infection.
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Malaria is well established as a major global health prob-
lem worldwide [1,2]. Malaria, Human Immunodeficiency
Virus (HIV) and tuberculosis are among the three most
important global health problems of developing coun-
tries. Both of them together, cause more than four mil-
lion deaths per year [2]. The co-infection exists in
many parts of the world. This is particularly true in
sub-Saharan Africa, where an estimated 40 million
people are living with HIV and more than 350 million
episodes of malaria occur yearly [1]. Malaria and HIV
infections are also the most deleterious conditions in
sub-Saharan African pregnant women, in terms of the
morbidity and mortality they cause in mothers and
their newborns [3-9].
In the DRC, malaria is reported to be the principal
cause of morbidity and mortality, especially among vul-
nerable population like pregnant women and children
less than five years of age. Close to 70% of all outpatient
health care visits and an average of 30% of hospital
admissions are malaria-related [10]. A recent study in
the DRC based on Demographic and Health Survey
(DHS) in 2007 showed an increase risk for malaria in
certain populations and regions of the DRC with higher
prevalence in rural area than urban [11]. In 2003,
UNAIDS estimated that the prevalence of HIV in adult
in DRC was 4.2% and 1.1 million people were living with
HIV/AIDS [12]. However, this prevalence among preg-
nant women was ranged from 2.7 to 5.4% in 1999 in
urban area and 8.5% in rural area [12].
Understanding the epidemiology of malaria and HIV
during pregnancy is important for deciding the best con-
trol strategies. Unfortunately, vital registration systems
in sub-Saharan African countries have low coverage and
do not produce accurate estimation of this co-infection.
Health workers in the Congolese Army are unable to
identify high or risk factors for both malaria and HIV in-
fections so as to tailor interventions and do effective
health monitoring. Moreover, pregnant women married
to soldiers and single soldiers are habitually facing
war-related poverty and human movements. There-
fore, the study aims were to determine the magnitude,
predictive factors, clinical, biologic and anthropomet-
ric consequences of malaria infection, HIV infection,




A prospective study for the prevalence of malaria, HIV
infection, HIV co-infection, and low birth weight from
pregnancy to delivery as well as a comparative study of
health consequences at the delivery was conducted from
2009 to 2012.Study site
The Camp Kokolo Military Hospital (HMRK) was the
study setting and is the largest public hospital in the
country, situated at the western part of Kinshasa, the
capital city of DRC. The town covers an area of
9,965.21 km2 with an estimated total population of
7,411,989 of whom more than 50% are female [13].
The HMRK provides antenatal services and has a well-
established prevention of mother-to-child transmis-
sion of HIV (PMTCT) programme.
Study population
All pregnant women who were suspected of malaria and
followed up in routine antenatal care service at HMRK
or hospitalized in the same hospital with at least one
antenatal visit between 2009 and 2012 were included to
this study (Figure 1).
Ethics statement
The institutional review boards and the Ethics Committee
of the University Protestant of Kinshasa approved the
protocol of the study (CEUPC 0018), which was con-
ducted in compliance with the principles of the Helsinki
Declaration II. Patients were informed about the research
purposes and gave written informed consent. The Ethics
Committee of the Université Protestante du Congo (UPC)
approved the consent procedure. The guidance of this
study was in the context of the routine diagnosis and of
normal medical care. Limited epidemiological, clinical
and biological information were collected anonymized.
Blood samples collection were also performed in the
context of the routine diagnosis and of normal medical
care for which the department of Tropical Medicine was
granted the agreement N/Réf: 007/UPC/SGAC/MM/AB/
2009 from the Medical faculty of UPC and the Faculty of
Medicine of the University of Kinshasa.
Data collection
Mothers were interviewed to obtain socio-demographic,
biographic, and clinical variables. These pregnant
women were tested using both blood films (thin and
thick blood smear) and polymerase chain reaction (PCR)
for the presence of Plasmodium, responsible for malaria
cases. Study participants who were positive for malaria
were treated. All mothers were provided a standard coun-
seling and were systematically screened for the presence
of HIV antibody by using Determine HIV 1/2 rapid
test kits (Abbott Diagnostic Division, Hoofddorp, The
Netherlands). At the delivery, birth weights of new-
borns were recorded using standard methods.
Definitions
The demographic details recorded were: age on admission
classified as follows: < 20 years, 20–24 and ≥ 25 years,
Figure 1 Study profile.
Wumba et al. Malaria Journal  (2015) 14:82 Page 3 of 11marital status (married spouses of soldiers vs. single
women as parents of soldiers), occupation (housewives
without income vs. others with income), and the district
of residence (urban for Funa, semi-urban for Amba, and
Rural for Lukunga). The laboratory variables were:
haemoglobin concentration (g/dL) and parasitaemia
(parasites/μL). Clinical variables were: history of fever,
body aches defines as the combination of asthenia and
muscle pain, headaches, nausea and vomiting, bleeding,
respiratory tract infection (rhinorrhoea and cough),
placenta previa, digestive disorders with gastritis, con-
stipation, diarrhoea and Salmonella infection.
Statistical analysis
The variables were summarized as frequencies, means
(standard deviation = SD), medians (interquartile range
= IQR). Differences in means between malaria-positive
and malaria-negative cases or between HIV-positive and
HIV-negative cases were compared using the Student’s
t-test or a non-parametric test, if appropriate. Categorical
variables were compared using the Chi-square or Fisher’sexact test, if appropriate. Backward multivariable analysis
was used to evaluate the potential risk factors of malaria
and HIV infections. The odds ratios with their 95% confi-
dence interval (95% CI) were estimated to measure the
strengths of the associations. Analyses resulting in values
of P < 0.05 were considered significant. All reported
p-values were two-tailed using Stata, version 12 (Stata
Corp, College station, Texas).
Results
Characteristics of the study population
Over the study period, a total of 1,200 pregnant women
attended the routine antenatal care services or hospital-
ized at MRHCK were screened, out of whom 348 were
eligible for the study. Out of these, 332 agreed to partici-
pate (95.4%) and were tested for malaria and HIV infec-
tions (Figure 1). Most of the women that participated in
the study were housewives (88.8%) and were married
(84.6%). The mean (±SD) age of participants was 28.6 ±
6.1 years and the median number of previous pregnan-
cies, number of children and abortion was three (range
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Additionally, around 40% were in the first trimester of
pregnancy. Overall, the mean (±SD) birth weight was
2613 ± 227 g, with 35.7% of newborns weighed less than
2,500 g.
Clinical examination and laboratory assessments of
malaria in pregnant women admitted to the study
The overall malaria parasite proportion was 74.1% (246/
332) and Plasmodium falciparum was the only species
detected in the positive malaria slide of pregnant women
whose peripheral blood smears were tested. Of the
332 pregnant women whose hemoglobin levels were
analyzed at enrolment, 31.9% (106/332) were anaemic
(Hb < 11.0 g/dL). Out of the 332 pregnant women who
were interviewed, 37.9% (126/332) had fever, 14.9% (49/
332) had headache and 3.5% (38/332) complained of
general body weakness whereas 39.8% (132/332) had re-
spiratory tract infection. Other symptoms included nau-
sea 7.5% (25/332), digestive disorder 10.5 (35/332) and
bleeding 6.9% (23/332). The geometric parasite density
and the 95% confidence interval (CI) in patients with
positive slide were 3383 (IQR = 2038-5618) parasites/μL.
Predictive factors associated with incident malaria
infection
Table 1 summarizes the risk factors associated with mal-
aria infection in pregnant women using univariate ana-
lysis. There was a significant association between urban/
Funa district, lack of income in housewives, higher parity
with ≥3 children, and incident malaria infection. Low
birth weight was more prevalent in presence of malaria
than in absence of malaria, the difference being statisti-
cally significant. In contrast, the rest of variables of
interest were not associated (p > 0.05) with malaria
presence. In multivariate analysis, after adjusting for
confounder residence, lack of income in housewives
(adjusted odds ratio = 3.3 95%CI 1.6 to 6.6; p < 0.001)
and higher parity (adjusted odds ratio = 1.9 95%CI 1.1 to
3.3; p = 0.04) remained significantly associated with inci-
dent malaria infection.
Prevalence of HIV-infection
Figure 2 shows the interrelationship between malaria in-
fection and HIV-infection. Of the 332 patients enrolled,
7.5% (25/332) were HIV-infected, with a median CD4
count of 375 (IQR = 191–669) cells/μL. Nineteen women
(6%) were both infected by malaria and HIV and six
(2%) were only infected by HIV. Table 2 summarizes the
levels of different associations between variables of inter-
est and HIV-infection. Only single marital status, urban
residence, fever, placenta previa, and anaemia were sig-
nificantly associated with HIV-infection. However, there
was no significant difference in rates of other variablesof interest between HIV-positive and HIV-negative
groups. In multivariate analysis and after adjusting for
confounders, placenta previa, fever, anaemia, marital
status, and urban residence were significantly and
independently associated with the presence of HIV-
infection (Table 2).
Contributing factors of low birth weight
Except of malaria infection, the rest variables were not
associated (P > 0.05) with (Table 3).
Roles of interactions between malaria and HIV infections
on variables of interest
Table 4 presents the comparisons of rates of variables of
interest across malaria alone, HIV-infection alone, mal-
aria + HIV-infections, and non-infected groups. The
highest proportions of low birth weight, fever, and an-
aemia were significantly concurrent in the interactions
between malaria and HIV-infections.
Discussion
Pregnancy is associated with increased susceptibility to
malaria in areas where malaria is endemic [14,15]. The
control of malaria and HIV in pregnant sub-Saharan
African women has, however, been particularly challen-
ging [16]. However, rare epidemiological data have been
recorded in the DRC, where P. falciparum malaria is
highly endemic [11]. This paper describess the preva-
lence of malaria and HIV infections of pregnant women
whose peripheral blood smears were tested.
Malaria infection
The proportion of malaria infection in pregnancy in this
study was 74.1% in Kinshasa where malaria transmission
is perennial and represents a substantial burden for the
local population [11]. This prevalence value is relatively
consistent with those found in previous studies. How-
ever, there is a large range of previously reported
prevalence values. For example, estimates of malaria
in pregnancy range from 6.8% in Calabar (Nigeria) to
57.5% in Libreville (Gabon) [17,18]. The applicability
of these prevalence rates is limited and muss be inter-
preted with caution since several articles investigating
the prevalence of infection disease have cited the lack
of national representation as a weakness. The results
of this study revealed consistently higher association
between malaria and occupation. Further evidence of
the relationships between occupation and malaria
infection were found in a study with a significantly
higher prevalence of malaria parasites in a low socio-
economic status occupational category [19-21].
By contrast with several study, fever was not signifi-
cantly associated with malaria infection in the following
study during pregnancy despite the fact that in endemic
Table 1 Demographic, clinical and laboratory test characteristics and adjusted odds ratios measuring the associations
between malaria infection and risk factors in pregnant women1, 2, 3
Characteristics Malaria infected pregnant women
Overall n (%) (N = 332) Malaria-positive (%) (N = 246) COR (95% CI) AOR (95% CI) P
Maternal age (years)
<20 21 (6.4%) 14 (66.7%) 1 0.6
20–24 75 (22.7%) 58 (77.3%) 1.7 (0.6-4.9)
> = 25 234 (70.9%) 173 (73.9%) 1.4 (0.5-3.7)
Number of previous pregnancies
Primigravidae 77 (23.3%) 56 (72.7%) 1
Multigravidae 253 (76.7%) 189 (74.7%) 0.8 (0.4-1.4) 0.3
Number of children
<3 182 (56.2%) 126 (69.2%) 1 1
≥3 142 (43.8%) 113 (79.6%) 1.7 (1.1-2.9) 1.9 (1.1-3.3) 0.04
Abortion
No abortion 97 (29.2%) 70 (72.2%) 1
Abortion 235 (70.8%) 176 (74.9%) 1.2 (0.7-2.0) 0.6
Trimester of visit
First-trimester 163 (49.1%) 122 (74.8%) 1 0.7
Second-trimester 88 (26.5%) 65 (73.9%) 1.2 (0.7-2.4)
Third-trimester 81 (24.4%) 59 (72.8%) 1.1 (0.6-2.3)
District of Kinshasa
Semi-urban for Amba 21 (6.3%) 13 (61.9%) 1 0.01
Urban for Funa 219 (66.0%) 173 (79.0%) 2.3 (1.2-5.9)
Rural for Lukunga 92 (27.7%) 60 (65.2%) 1.2 (0.4-3.1)
Occupation
Others with income 37 (11.2%) 19 (51.4%) 1 1
Housewives without income 294 (88.8%) 226 (76.9%) 3.1 (1.6-6.3) 3.3 (1.5-6.5) 0.005
Marital status
Single women as parents of soldiers 50 (15.4%) 1
Married spouses of soldiers 275 (84.6%) 209 (76.0%) 1.8 (0.9-3.4) 0.07
Low Birth Weight (LBW)
≥2500 g 213 (64.3%)
<2500 g 118 (35.7%) 113 (44.9%) <0.001
Examination findings
Anaemia (haemoglobin < 11 g/dL), % 106 (31.9%) 76 (71.7%) 0.5 (0.4-1.4)
Fever 123 (38.0%) 92 (73.0%) 0.9 (0.6-1.5) 0.7
Body aches 38 (11.5%) 25 (65.8%) 0.6 (0.3-1.3) 0.2
Headaches 49 (18.8%) 37 (75.5%) 1.1 (0.5-2.2) 0.8
Digestive disorders 8 (2.4%) 6 (75.0%) 1.1 (0.2-5.3) 0.9
Nausea and vomiting 25 (7.5%) 18 (72.0%) 0.9 (0.3-2.2) 0.8
Respiratory infection 132 (39.8%) 9 (75.0%) 0.8 (0.5-1.4) 0.6
Bleeding 23 (6.9%) 18 (78.3%) 1.3 (0.4-3.6) 0.6
Urinary tract infection 223 (67.2%) 156 (70.0%) 0.5 (0.3-0.8) 0.5 (0.3-0.9) 0.04
Gastritis 24 (7.2%) 18 (75.0%) 1.1 (0.4-2.7) 0.9
1CI = confidence interval; COR = Crude odds ratios; AOR = Adjusted odds ratios. 2Factors included in the logistic regression model were: age, marital status,
occupation, urinary tract infection and HIV status. 3All P-values were estimated through Wald tests in adjusted logistic regression models. The model included both
Malaria-infected and uninfected pregnant women, adjusting for other predictors.
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Figure 2 Venn diagram showing inter-relationship between
malaria and HIV infections.
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in adults [21-23]. Fever alone remains a poor discrimin-
ator of malaria infection, suggesting that all fevers
should be tested to confirm or refute the role of malaria
in the febrile presentation [22]. This result may be due
to some comorbidity.
HIV-infection
The prevalence of HIV infection was 7.5% in the present
study. This result is higher than the previous 4.2% re-
ported in DRC by UNAIDS in 2003 [12]. A number of
factors that facilitate further the spread of HIV in DRC
included ignorance which refers to the lack of informa-
tion, fear and stigma, the flux of refugees and soldiers,
scarcity and high cost of safe blood transfusions in rural
areas, few HIV testing sites, and low availability of con-
doms outside Kinshasa [12].
The impact of HIV/AIDS and Malaria in pregnant women
The prevalence of HIV infection was associated to mal-
aria in 5.7% (Figure 2). Malaria prevalence increased
considerably in HIV-infected women to reach 76.0%. In
areas with stable malaria transmission like DRC, HIV in-
creases the risk of malaria infection and clinical malaria
in adults, especially in those with advanced immunosup-
pression. In addition, HIV-infected adults are at in-
creased risk of complicated and severe malaria and
death [3-9,17,23].
Every year, approximately 25 million women become
pregnant in sub-Saharan Africa, where malaria is
endemic, and are at increased risk of infection with
P. falciparum, particularly in their first two pregnancies
[23]. Interactions between the two infections can have
serious consequences, particularly for pregnant women.
HIV-infected pregnant women who become infected
with malaria are at increased risk of all the adverse out-
comes of malaria in pregnancy. Co-infected pregnant
women are more likely to have symptomatic malariainfections, anaemia, placental malaria infection, and low
birth weight. Epidemiological studies assessing the im-
pact of placental malaria on mother-to-child transmis-
sion of HIV have thus far been inconsistent [3-9,17,23].
Risk factors of HIV infection
On multivariate analysis, HIV-infection was significantly
associated with fever, anaemia, placenta previa, marital
status, and district of residence. This finding character-
ized the impact of anaemia and fever related to P. falcip-
arum malaria and HIV infection in pregnant women. It
has been shown that many studies in Africa shows that
co-infection with HIV influences the burden of malaria
in pregnancy. HIV increases the degree to which malaria
is associated with severe anemia and low birth weight
beyond the effect of HIV itself on these outcomes. HIV
also puts women of all gravidities at risk for placental in-
fection with malaria, not only women in their first or
second pregnancy [3-5,7-9,15,23]. In addition, higher
HIV prevalence rates exceeding sometime 40% have
been reported among pregnant women in malaria en-
demic region of Africa [24]. Unfortunately, the analysis
of this study did not show a significant association be-
tween malaria and HIV infections (p = 0.8). This can be
explained by the low number of HIV-infected patients.
Low birth weight
LBW was highly associated to malaria infection in preg-
nant women. It is estimated that in areas where malaria
is endemic, around 19% of infant LBWs are due to mal-
aria and 6% of infant deaths are due to LBW caused by
malaria [25,26].
Limitations
Although the present study has yielded some important
preliminary findings in regard of malaria and HIV
infections in pregnant women in DRC, its design is not
without flaws. A number of caveats need to be noted
regarding the present study. First, as a cross-sectional
design, it does not allow us to make any causal infer-
ences from these findings. Second limitation concerns
the restriction of the inclusion criteria and the absence
of real follow-up due to the difficulty to enroll patients.
Third, there were a relatively small number of HIV-
infected pregnant women. While 332 patients were
initially enrolled, only 5.7% were infected. In that case, it
was relevant to examine the association between HIV-
infected women and uninfected women in depth. Further-
more, the lack of unmeasured factors may bias these re-
sults. Another limitation was the challenge to collected
data. Most women in this study were uneducated and were
embarrassed to answer questions. In other cases, data in
registers were absent or poorly reported.
Table 2 Demographic, clinical and laboratory test characteristics of pregnant women infected with HIV1, 2, 3, 4, 5
HIV+(N = 25) HIV-(N = 307) AOR (95% CI) P-value
Demographic Characteristics
Age in years, mean ± SD 29.4 ± 7.2 28.5 ± 6.0 0.6
<20 20 (6.7%) 1 (4.0%)
20–24 68 (22.3%) 7 (28.0%) 0.6
> = 25 217 (71.0%) 17 (68.0%)
LBW (<2500gr) 12 (48.0%) 106 (34.6%) 0.2
Single women as parents of soldiers, (%) 4 (16.0%) 273 (10.8%) 3.5 (1.1-11.2) 0.04
Occupation, (%)
Housewives without income 21 (84.0%) 273 (89.2%) 0.4
Number of previous pregnancies, (%)
Primigravidae 6 (24.0%) 71 (23.3%)
Multigravidae 19 (76.0%) 234 (76.7%) 0.9
Number of children, (%)
<3 16 (64.0%) 166 (55.5%) 0.4
> = 3 9 (36.0%) 133 (44.5%)
Number of abortion, (%)
No abortion 10 (40.0%) 87 (28.3%)
Abortion 15 (60.0%) 220 (71.7%) 0.2
Trimester of visit, (%)
First-trimester 12 (48.0%) 151 (49.2%)
Second-trimester 8 (32.0%) 80 (26.1%) 0.7
Third-trimester 5 (6.2%) 76 (24.8%)
District of Kinshasa, (%)
Rural for Lukunga 4 (16.0%) 88 (28.7%) 1
Semi-urban for Amba 4 (16.0%) 17 (5.5%) 10.6 (1.8-62.7)
Urban for Funa 17 (68.0%) 202 (65.8%) 2.9 (0.8-10.6) 0.03
Examination findings
Fever, (%) 20 (80.0%) 5 (34.0%) 9.4 (2.9-30.0) <0.001
Body aches, (%) 1 (4.0%) 37 (12.1%) 0.3
Headaches, (%) 5 (10.2%) 20 (7.1%) 0.4
Digestive disorders, (%) 2 (8.0%) 33 (10.8%) 0.7
Nausea and vomiting, (%) 2 (8.0%) 23 (7.5%) 0.9
Respiratory infection, (%) 12 (48.0%) 120 (39.1%) 0.4
Bleeding, (%) 0 23 (7.5%) 0.2
Placenta previa, (%) 3 (12.0%) 27 (8.8%) 11.9 (1.4-104.5) <0.0001
Urinary tract infection, (%) 14 (56.0%) 208 (67.8%) 0.2
Laboratory tests
Haemoglobin (g/dL), mean ± SD 11.8 ± 4.8 13.8 ± 4.4 0.04
Anaemia (haemoglobin < 11 g/dL), %4 16 (64.0%) 92 (30.0%) 4.1 (1.6-10.8) <0.001
1IQR = interquartile range; SD = standard deviation. 2 To compare HIV+ and HIV-, Pearson chi-square tests and Fisher’s exact test were used to compare proportions,
ttest and Kruskal-Wallis tests were used to compare continuous variables. 3 Sample sizes reported in this table and used for estimation of proportions include subjects
with outcome missing. 4Factors included in the logistic regression model were: district of residence, marital status, occupation, fever, placenta previa and anaemia.
5All P-values were estimated through Wald tests in adjusted logistic regression models. The model included both HIV-infected and uninfected pregnant women,
adjusting for other predictors.
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Table 3 Demographic, clinical and laboratory test characteristics and adjusted odds ratios measuring the associations
between LBW and risk factors in pregnant women
LBW (N = 118) NBW* (N = 213) COR (95% CI) AOR (95% CI) P-value
Demographic Characteristics
Maternal age (years)
<20 7 (5.9%) 14 (6.6%) 1
20–24 25 (21.2%) 50 (23.7%) 0.8(0.3-2.3)
> = 25 86 (72.9%) 147 (69.7%) 1.2(0.5-3.2) 0.9
Marital status, (%)
Married spouses of soldiers 102 (88.7%) 172 (82.3%) 1.0
Single women as parents of soldiers 13 (11.3%) 37 (17.7%) 0.7(0.3-1.3) 0.1
Occupation, (%)
Others with income 9 (7.7%) 28 (13.2%) 1
Housewives without income 108 (92.3%) 185 (89.9%) 0,4(0.1-1.7) 0.1
Number of previous pregnancies, (%)
Primigravidae 32 (27.1%) 45 (21.3%) 1.0
Multigravidae 86 (72.9%) 166 (78.7%) 0.8(0.5-1.3) 0.2
Number of children, (%)
<3 52 (63.9%) 119 (57.2%) 1.0
> = 3 53 (49.1%) 89 (42.8%) 1.5(0.9-2.4) 0.6
Number of abortion, (%)
No abortion 34 (28.8%) 62 (29.1%) 1.0
Abortion 84 (71.2%) 151 (70.9%) 1.1(0.6-1.7) 0.9
Trimester of visit, (%)
First-trimester 63 (53.4%) 100 (47.0%) 1.0
Second-trimester 31 (26.3%) 57 (26.8%) 0.8(0.5-1.4) 0.4
Third-trimester 24 (20.3%) 56 (26.3%) 0.8(0.5-1.4)
District of Kinshasa, (%)
Rural for Lukunga 30 (25.4%) 62 (29.1%) 1.0
Semi-urban for Amba 8 (6.8%) 13 (6.1%) 2.1(0.8-5.5) 0.3
Urban for Funa 80 (67.8%) 132 (64.8%) 1.4(0.8-2.3)
Examination findings 1.1(0.8-1.7)
Fever, (%) 46 (39.0%) 81 (38.0%) 1.1(0.7-1.7)
Body aches, (%) 8 (6.8%) 30 (14.1%) 1.2(0.6-2.4) 0.04
Headaches, (%) 15 (12.7%) 34 (16.0%) 1.4(0.8-2.6) 0.4
Digestive disorders, (%) 11 (9.3%) 24 (11.3%) 0.6(0.3-1.3) 0.6
Nausea and vomiting, (%) 5 (4.2%) 20 (9.3%) 1.7(0.8-3.9) 0.09
Respiratory infection, (%) 52 (44.1%) 80 (37.6%) 1.4(0.9-2.1) 0.2
Bleeding, (%) 10 (8.5%) 13 (6.1%) 0.9(0.4-2.3) 0.4
Placenta previa, (%) 13 (11.0%) 17 (8.0%) 1.1(0.5-2.3) 0.3
Urinary tract infection, (%) 70 (59.3%) 151 (70.9%) 0.9(0.5-1.4) 0.03
Laboratory tests
Anaemia (haemoglobin < 11 g/dL), (%4) 35 (29.7%) 73 (34.3%) 1.1(0.6-1.7) 0.3
Outcome
Malaria infection, (%) 111 (94.1%) 134 (62.9%) 7.0(3.3-14.5) 8.7 (3.8-19.7) <0.001
*NBW = normal birth weight.
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None (N = 80) P-value
Demographic Characteristics
Maternal age (years)
< 20 13 (5.8%) 0 (0.0%) 1 (5.3%) 7 (8.9%)
20–24 51 (22.6%) 0 (0.0%) 7 (36.8%) 17 (21.5%)
> = 25 132 (71.6%) 6 (100.0%) 11 (57.9%) 55 (69.6%) 0.5
Marital status
Married spouses of soldiers 194 (87.4%) 5 (50.0%) 15 (79.0%) 63 (80.8%)
Single women as parents of soldiers 28 (12.6%) 5 (50.0%) 4 (21.0%) 15 (19.2%) 0.04
Occupation, (%)
Others with income 15 (6.6%) 0 (0.0%) 4 (21.1%) 18 (22.5%)
Housewives without income 211 (93.4%) 6 (100.0%) 15 (79.0%) 62 (77.5%) 0.001
Number of previous pregnancies, (%)
Primigravidae 50 (22.1%) 0 (0.0%) 6 (31.6%) 21 (26.6%)
Multigravidae 176 (77.9%) 6 (100.0%) 13 (68.4%) 58 (73.4%) 0.4
Number of children, (%)
<3 114 (51.8%) 4 (66.7%) 12 (63.2%) 52 (65.8%)
> = 3 106 (48.2%) 2 (33.3%) 7 (36.8%) 27 (34.2%) 0.1
Number of abortion, (%)
Abortion 166 (73.1%) 5 (83.3%) 10 (52.6%) 54 (67.5%) 0.2
Trimester of visit, (%)
First-trimester 112 (49.3%) 2 (33.3%) 10 (52.6%) 39 (48.7%)
Second-trimester 60 (26.4%) 3 (50.0%) 5 (26.3%) 20 (25.0%)
Third-trimester 55 (24.3%) 1 (16.7%) 4 (21.1%) 21 (26.3%) 0.9
District of Kinshasa, (%)
Semi-urban for Amba 11 (4.8%) 2 (33.3%) 2 (10.5%) 6 (7.5%)
Urban for Funa 160 (70.5%) 4 (66.7%) 13 (68.4%) 42 (52.5%) 0.005
Rural for Lukunga 56 (24.7%) 0 (0.0%) 4 (21.1%) 32 (40.0%)
LBW, (%) 101 (44.7%) 2 (33.3%) 10 (52.6%) 5 (6.3%) <0.001
Examination findings, (%)
Fever 74 (32.6%) 2 (33.3%) 19 (100.0%) 32 (40.0%) <0.001
Body aches 24 (10.7%) 0 (0.0%) 1 (5.3%) 13 (16.3%) 0.3
Headaches 33 (14.5%) 1 (16.7%) 4 (21.1%) 11 (13.8%) 0.8
Digestive disorders 24 (10.6%) 0 (0.0%) 2 (10.5%) 9 (11.3%) 0.8
Nausea and vomiting 17 (7.5%) 1 (16.7%) 1 (5.3%) 6 (7.5%) 0.8
Respiratory infection 89 (39.2%) 5 (83.3%) 7 (36.8%) 31 (38.7%) 0.1
Bleeding 18 (7.9%) 0 (0.0%) 0 (0.0%) 5 (6.3%) 0.5
Placenta previa 20 (8.8%) 0 (0.0%) 3 (15.8%) 7 (8.7%) 0.6
Urinary tract infection 147 (64.8%) 6 (100.0%) 8 (42.1%) 61 (76.2%) 0.008
Laboratory Tests, (%)
Anemia (haemoglobin < 11 g/dL)4 74 (32.6%) 3 (50.0%) 13(68.4%) 22 (27.5%) 0.004
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Malaria in pregnancy
The present findings will impact on clinical practice and
public health related to malaria in pregnant women. In
obtaining as much relevant socioeconomic information
(income, poor nutrition, residence, indoor pollution,
HIV-infection, tuberculosis) as possible, present results
will help to understand the pathophysiology and to apply
the epidemiology evidence in clinical practice and public
health. The consequences of socioeconomic deprivation
on pregnancy outcomes are anaemia and low birth
weight [27]. Policy makers are invited to improve social
status and income levels of pregnant women married to
soldiers at curbing the high burden of malaria itself and
malaria adverse (anaemia and low birth weight). As rec-
ommended by the WHO, [28] the United Nations Joint
Program programme on HIV/AIDS and different au-
thors, future Congolese Studies will assess effectiveness
of co-trimoxazole to prevent malaria in HIV-positive
pregnant women [29,30].
Prevention of malaria in Congolese pregnant women
might rely on intermittent preventive treatment with
sulphadoxine-pyrimethamine, which reduces higher
probability of placental parasitaemia, anaemia, and
low birth weight [31,32]. Thus, good clinical practice
will avoid IPT-SP-related resistance and initiation of
IPT-SP before 16 weeks of pregnancy [33]. Furthermore,
co-trimoxazole provides coverage for opportunistic HIV-
associated infections and anti-malarial activities [34].
Conclusions
There is evidence of high prevalence of malaria and HIV
infections in Congolese pregnant women. Prevention
and surveillance of infectious diseases progression are
needed to reduce the incidence of malaria and HIV in-
fections in pregnant women in DRC by improving better
management and public health panel control. Qualitative
research should be encouraged to obtain more in depth,
locally-relevant, and descriptive data examining the im-
pact of infectious diseases in DRC.
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